Medical Communications
WHO says world still unprepared for future pandemics even after COVID-19
May 20, 2022 Medical Communications
An expert panel has said that the world is still not ready for future pandemics, despite having years to prepare …
Collaboration to boost access to cancer medicines in low- and middle-income countries
May 20, 2022 Medical Communications
Novartis, Roche, and other pharmaceutical companies have formed a coalition with global cancer organisations in an aim to get more …
ANGLE technology could alter how prostate cancer is treated
May 20, 2022 Medical Communications
Researchers from Barts Cancer Institute will use ANGLE’s new technology, Parsortix, to isolate and assess circulating tumour cells as a …
Evotec and Sernova collaborate into beta cell replacement therapy for diabetes
May 17, 2022 Medical Communications
Evotec and Sernova have announced an exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a ‘functional cure’ …
Breast cancer ‘metal detector’ recommended to NHS
May 17, 2022 Medical Communications
A recommendation by the government’s health advisers have said that women with invasive breast cancer could be injected with a …
60,000 NHS staff believed to suffer pandemic-related PTSD
May 13, 2022 Medical Communications
As many as 60,000 NHS staff are believed to be suffering from post-traumatic stress brought on by the COVID-19 pandemic, …
New national guidance addressing sepsis
May 13, 2022 Medical Communications
New guidelines proposing significant changes to the way people with suspected sepsis are treated with antibiotics have been published. The …
WHO launches first ever global report on Infection Prevention and Control
May 6, 2022 Medical Communications
A new report from WHO has highlighted the importance of effective IPC programmes, and shown that where good hand hygiene …
Open Orphan to begin first-ever COVID-19 challenge trial
May 6, 2022 Medical Communications
Open Orphan has been appointed by an unnamed existing “big pharma” client to host a Phase II field study of …
FDA narrows use of J&J vaccine due to blood clot risk
May 6, 2022 Medical Communications
The FDA has limited the use of Johnson & Johnson’s coronavirus vaccine, to adults who cannot, or refuse to get, …
AstraZeneca’s heart disease drug meets key endpoints in Phase III
May 6, 2022 Medical Communications
AstraZeneca’s treatment for heart disease has delivered positive high-level results from its Phase III DELIVER trial.Farxiga (dapagliflozin) is already approved …
Discharging untested patients to care homes was ‘unlawful’, says high court ruling
April 29, 2022 Medical Communications
The High Court has ruled that government policies on discharging untested patients from hospital to care homes in England, at …
Pfizer DMD trial moves forward after FDA lifts hold
April 29, 2022 Medical Communications
Pfizer has announced that it will open the first ever US sites in its Phase III trial study, evaluating its …
FDA approval for first drug to treat inherited heart condition
April 29, 2022 Medical Communications
Bristol Myers Squibb has received approval from the FDA for their drug, Camzyos™ (mavacamten), marking the drug as the first …
Beijing enforces mass COVID-19 testing and closes neighbourhoods
April 26, 2022 Medical Communications
Beijing is enforcing mass testing and closing down access to neighbourhoods as it seeks to contain a new COVID-19 outbreak. …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
